Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HYTE Research is a Cambridge-based biotechnology company dedicated to the advancement of circular RNA (circRNA) therapeutics. Founded by Dr. Alex Wesselhoeft, a leading expert in RNA engineering and a co-founder of Orna Therapeutics, the company focuses on developing a proprietary platform for high-efficiency RNA medicines. By utilizing circularized RNA structures, HYTE Research aims to improve the stability, translation efficiency, and delivery of genetic medicines compared to traditional linear mRNA. The company operates primarily in the pre-clinical stage, targeting a range of therapeutic areas through its innovative RNA engineering approach. HYTE Research is positioned at the forefront of the next wave of RNA-based treatments, seeking to address unmet medical needs in oncology and rare diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HYTE Research.